Weight Management
Semaglutide
GLP-1 receptor agonist for sustainable weight management and metabolic health.
Tirzepatide
Tirzepatide represents an advancement in weight management and metabolic health therapies, with dual-action targeting of both GIP and GLP-1 receptors. This mechanism may contribute to weight reduction, glycemic control, and cardiovascular effects through its action on appetite regulation, insulin secretion, and metabolism.
- Significant weight loss, often exceeding other GLP-1 medications
- Improved blood sugar control and insulin sensitivity
- Reduction in cardiovascular risk factors
- Decreased appetite and increased satiety
- Once-weekly convenient dosing
HSA/FSA reimbursable
No insurance required
Licensed US pharmacies
Select Your Supply
Tirzepatide is a novel dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist that supports weight management, blood sugar control, and metabolic health. This once-weekly injectable medication offers benefits for those looking to achieve sustainable weight loss and improve metabolic parameters.
Who Can Benefit from Tirzepatide?
Tirzepatide is primarily indicated for individuals seeking weight management solutions or those with type 2 diabetes looking to improve glycemic control.
1
Overweight or obesity with weight-related health concerns
For those struggling with excess weight, particularly with BMI >27 with a weight-related comorbidity or BMI >30, tirzepatide offers a powerful tool for achieving significant and sustained weight reduction.
2
Type 2 diabetes requiring improved glucose control
Patients with type 2 diabetes often experience substantial improvement in glycemic control, with many achieving target HbA1c levels and some reaching normoglycemic ranges.
3
Metabolic syndrome
Individuals with metabolic syndrome can benefit from tirzepatide's ability to address multiple parameters including weight, blood glucose, and lipid profiles simultaneously.
4
Insulin resistance
Those with insulin resistance may experience improved sensitivity to insulin and better metabolic function, reducing the progression toward diabetes.
5
Prediabetes
For individuals with prediabetes, tirzepatide may help prevent or delay the onset of type 2 diabetes while supporting weight management goals.
6
Cardiovascular risk factors related to weight
People with weight-related cardiovascular risk factors often see improvements in blood pressure, lipid profiles, and inflammatory markers, potentially reducing overall cardiac risk.
How Tirzepatide Works
Tirzepatide is the first dual GIP and GLP-1 receptor agonist, activating two incretin hormone pathways simultaneously. By binding to and activating both GIP and GLP-1 receptors, tirzepatide affects multiple systems involved in metabolism, appetite regulation, and blood sugar control. This dual-receptor activation appears to have synergistic effects, potentially explaining why tirzepatide often achieves greater weight loss and metabolic improvements compared to medications that target GLP-1 receptors alone.
How It Works in Your Body
Slows gastric emptying, leading to increased feelings of fullness
Reduces appetite and food intake via hypothalamic regulation
Enhances glucose-dependent insulin secretion from pancreatic beta cells
Decreases glucagon secretion, reducing glucose production by the liver
Improves insulin sensitivity in peripheral tissues
May increase energy expenditure and fat utilization
More Weight Management Treatments
Explore our other treatment options that may complement or offer alternatives to Tirzepatide.
Explore Our Programs
Discover more specialized treatments and services offered at Fountain
Frequently Asked Questions
Everything you need to know about Tirzepatide treatment
Ready to Transform Your Metabolic Health?
Compounded medications provided through Fountain Health's platform are only available to patients with a valid prescription who medically qualify after consultation with a licensed health care practitioner. Compounded medications are not FDA-approved — they have not undergone FDA review for safety or efficacy before being dispensed, and have not been demonstrated to the FDA to be safe or effective. Stylized product images are for marketing purposes only and do not reflect the actual label or size of the prescription vial or bottle.